科前生物新兽药获批 丰富产品线

Group 1 - The core viewpoint of the article is that the company, Keqian Biotechnology, has received approval from the Ministry of Agriculture and Rural Affairs for a new veterinary drug registration certificate for a vaccine aimed at preventing diseases caused by Porcine Circovirus Type 2 [1][2] - The approved product is a recombinant virus-inactivated vaccine (CH17 strain, suspension culture) specifically designed for the prevention of Porcine Circovirus Type 2 infections [1][2] - The approval will enrich the company's product line, but the market promotion and sales situation remain uncertain until the product obtains the necessary approval number for market sales [1]